Thomson Medical Group Limited (SGX:A50)

Thomson Medical Group Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	58.04	72.84	70.13	78.02	60.64
Short-Term Investments	47.07	41.18	80.11	211.25	93
Cash & Short-Term Investments	105.11	114.02	150.24	289.27	153.64
Cash Growth	-7.82%	-24.11%	-48.06%	88.27%	34.18%
Accounts Receivable	62.9	56.52	43.38	35.36	37.43
Other Receivables	-	-	-	22.98	18.76
Receivables	62.9	56.52	43.38	58.33	56.19
Inventory	147.77	138.82	106.19	91.82	98.81
Prepaid Expenses	-	-	-	1.47	1.22
Other Current Assets	7.98	10.19	17.04	-	10.69
Total Current Assets	323.75	319.55	316.84	440.88	320.55
Property, Plant & Equipment	512.93	498.73	489.47	430.55	457.45
Long-Term Investments	0.48	3.9	2.39	2.78	2.34
Goodwill	759.32	788.06	858.37	474.78	483.37
Other Intangible Assets	32.13	36.95	38.33	6.87	0.69
Long-Term Deferred Tax Assets	0.33	0.36	0.25	0.61	0.92
Other Long-Term Assets	145.27	137.04	103.79	91.31	99.63
Total Assets	1,774	1,785	1,809	1,448	1,365

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	87.57	84.25	80.65	12.72	13.33
Accrued Expenses	-	-	-	44.42	46.12
Current Portion of Long-Term Debt	201.92	163.94	189.18	12.13	227.68
Current Portion of Leases	10.19	7.55	6.86	6.56	5.31
Current Income Taxes Payable	5.93	7.24	8.83	13.89	15.17
Current Unearned Revenue	5.41	5.78	6.57	3.64	3.8
Other Current Liabilities	-	-	-	26.67	27.09
Total Current Liabilities	311.02	268.77	292.1	120.04	338.5
Long-Term Debt	902.34	942.66	917.02	735.63	401.42
Long-Term Leases	15.98	8.1	8.3	8.48	8.45
Long-Term Unearned Revenue	0.6	0.41	0.33	-	-
Long-Term Deferred Tax Liabilities	17.49	14.94	13.91	7.33	7.35
Other Long-Term Liabilities	1.3	1.28	0.8	0.86	0.88
Total Liabilities	1,249	1,236	1,232	872.34	756.6

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	2,365	2,365	2,365	2,365	2,365
Retained Earnings	82.04	111.34	158.44	154.82	148.55
Comprehensive Income & Other	-2,004	-2,005	-2,023	-2,020	-1,981
Total Common Equity	442.4	470.9	499.72	499.44	531.68
Minority Interest	83.08	77.53	77.27	76	76.66
Shareholders' Equity	525.49	548.43	577	575.44	608.34
Total Liabilities & Equity	1,774	1,785	1,809	1,448	1,365

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	1,130	1,122	1,121	762.79	642.86
Net Cash (Debt)	-1,025	-1,008	-971.13	-473.53	-489.21
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.04	-0.04	-0.04	-0.02	-0.02
Filing Date Shares Outstanding	26,444	26,441	26,441	26,441	26,441
Total Common Shares Outstanding	26,444	26,441	26,441	26,441	26,441
Working Capital	12.73	50.78	24.75	320.85	-17.95
Book Value Per Share	0.02	0.02	0.02	0.02	0.02
Tangible Book Value	-349.05	-354.12	-396.98	17.8	47.62
Tangible Book Value Per Share	-0.01	-0.01	-0.02	0.00	0.00
Land	-	-	-	226.17	232.66
Buildings	-	-	-	172.99	156
Machinery	-	-	-	87.3	89.82
Construction In Progress	-	-	-	27.01	35.26

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 2, 2026

Data Sources Report a data error